Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Pilot Clinical Study to Evaluate the Feasibility of Using the SPC Test
Sponsor: Novomics. Co., Ltd.
Summary
Precision medicine approaches emphasize the importance of reliable prognostic tools for guiding individualized therapy decisions. In this study, we evaluated the clinical feasibility of the Single Patient Classifier (SPC) test, a new clinical-grade prognostic assay, in stage II-III gastric cancer patients.
Official title: A Pilot Clinical Study to Evaluate the Feasibility of Using the Single Patient Classifier as a Prognostic Test in Stage II-III Gastric Cancer Patients.
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
OBSERVATIONAL
Enrollment
237
Start Date
2019-09-01
Completion Date
2025-12-31
Last Updated
2024-07-29
Healthy Volunteers
No
Conditions
Interventions
nProfiler I Stomach Cancer Assay Kit
nProfiler I Stomach Cancer Assay Kit (Novomics Co., Korea)
Locations (1)
Novomics. Co., Ltd.
Seoul, South Korea